HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ralph A. Schmid Walter Weder Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmid, R. A. Articles by Schoedon, G. Search for Related Content PubMed PubMed Citation Articles by Schmid, R. A. Articles by Schoedon, G.

J Thorac Cardiovasc Surg 1999;118:726-732
© 1999 Mosby, Inc.

CARDIOTHORACIC TRANSPLANTATION

THE NITRIC OXIDE SYNTHASE COFACTOR TETRAHYDROBIOPTERIN REDUCES ALLOGRAFT ISCHEMIA-REPERFUSION INJURY AFTER LUNG TRANSPLANTATION

From the Department of Surgery, Division of Thoracic Surgery,^a Department of Medicine, Medical Clinic B,^b and Department of Anesthesiology,^c University Hospital, Zürich, Switzerland.

Supported by Swiss National Science Foundation grants 32-46004.95 (R. A. Schmid) and 32-42536.94 (G. Schoedon).

Address for reprints: Ralph A. Schmid, MD, Department of Surgery, University Hospital, Zürich, Rämistr 100, CH-8091 Zürich, Switzerland.

Objective: Exogenous nitric oxide reduces ischemia-reperfusion injury after solid organ transplantation. Tetrahydrobiopterin, an essential cofactor for nitric oxide synthases, may restore impaired endothelium-dependent nitric oxide synthesis. We evaluated whether tetrahydrobiopterin administration to the recipient attenuates lung reperfusion injury after transplantation in swine.
Methods: Unilateral left lung transplantation was performed in 15 weight-matched pigs (24-31 kg). Donor lungs were flushed with 1.5 L cold (1°C) low-potassium-dextran solution and preserved for 20 hours. Group I animals served as controls. Group II and III animals were treated with a bolus of tetrahydrobiopterin (20 mg/kg). In addition, in group III a continuous infusion of tetrahydrobiopterin (10 mg/kg per hour over 5 hours) was given. One hour after reperfusion, the recipient right lung was occluded. Cyclic guanosine monophosphate levels were measured in the pulmonary venous and central venous blood. Extravascular lung water index, hemodynamic variables, lipid peroxidation, and neutrophil migration to the allograft were assessed.
Results: In group III a significant reduction of extravascular lung water was noted in comparison with the controls (P = .0047). Lipid peroxidation in lung allograft tissue was significantly reduced in group II (P = .0021) and group III ( P = .0077) in comparison with group I. Pulmonary venous levels of cyclic guanosine monophosphate increased up to 23 ± 1 pmol/mL at 5 hours in group II and up to 40 ± 1 pmol/mL in group III (group I, 4.1 ± 0.5 pmol/mL [I vs III]; P < .001), whereas central venous levels of cyclic guanosine monophosphate were unchanged in all groups.
Conclusion: Tetrahydrobiopterin administration during lung allograft reperfusion may reduce posttransplantation lung edema and oxygen-derived free radical injury in the graft. This effect is mediated by local enhancement of the nitric oxide/cyclic guanosine monophosphate pathway.

This article has been cited by other articles:

				M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF]

				S. Yamashiro, K. Noguchi, T. Matsuzaki, K. Miyagi, J. Nakasone, M. Sakanashi, K. Koja, and M. Sakanashi Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 775 - 784. [Abstract] [Full Text] [PDF]

				S. Verma, A. Maitland, R. D. Weisel, P. W. M. Fedak, N. C. Pomroy, S.-H. Li, D. A. G. Mickle, R.-K. Li, and V. Rao Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1074 - 1083. [Abstract] [Full Text] [PDF]

				M. R. Karamsetty and J. R. Klinger NO: More Than Just a Vasodilator in Lung Transplantation Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 1 - 5. [Full Text] [PDF]

				S. Hillinger, P. Sandera, G. L. Carboni, U. Stammberger, M. Zalunardo, G. Schoedon, and R. A. Schmid Survival and graft function in a large animal lung transplant model after 30 h preservation and substitution of the nitric oxide pathway Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 508 - 513. [Abstract] [Full Text] [PDF]

				Z. S. Katusic Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H981 - H986. [Abstract] [Full Text] [PDF]